DC
Decheng Capital LLC
13F filer · CIK 0002010850Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$732MU.S. long equity reported on 13F
Positions141 new · 1 closed
Net flow last quarter-$15.2MBuys minus sells
Top 10 positions weight98.1%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 202614 positions | |||||
| $453M | 61.87% | 7.22% | Not reported | Q1 2024 | |
| $147M | 20.15% | 7.49% | Not reported | Q2 2024 | |
| $22.6M | 3.08% | 17.90% | Not reported | Q1 2025 | |
| $21.4M | 2.92% | 2.89% | Not reported | Q4 2024 | |
| $18.9M | 2.58% | 4.98% | Not reported | Q4 2024 | |
| $14.3M | 1.96% | 0.37% | -2.7% | Q4 2023 | |
| $14.2M | 1.94% | 7.01% | Not reported | Q4 2023 | |
| $9.86M | 1.35% | 0.02% | -43.7% | Q3 2024 | |
| $9.72M | 1.33% | 2.96% | Not reported | Q4 2024 | |
| $6.65M | 0.91% | 9.24% | Not reported | Q4 2023 | |
| $6.42M | 0.88% | 1.85% | Not reported | Q4 2023 | |
| $5.99M | 0.82% | 0.15% | -45.6% | Q2 2024 | |
| $984K | 0.13% | 0.52% | Not reported | Q4 2023 | |
| $625K | 0.09% | 0.01% | New | Q2 2026 | |
| Q1 2026Reported May 13, 202614 positions | |||||
| $431M | 65.21% | 7.24% | Not reported | Q1 2024 | |
| $111M | 16.84% | 7.49% | -2.4% | Q2 2024 | |
| $24.5M | 3.71% | 5.01% | -13.3% | Q4 2024 | |
| $15.2M | 2.29% | 2.89% | Not reported | Q4 2024 | |
| $14.8M | 2.23% | 17.96% | Not reported | Q1 2025 | |
| $13.9M | 2.10% | 2.97% | Not reported | Q4 2024 | |
| $10.4M | 1.57% | 0.28% | -45.1% | Q2 2024 | |
| $10.3M | 1.56% | 0.38% | -11.8% | Q4 2023 | |
| $9.09M | 1.37% | 0.05% | -53.3% | Q3 2024 | |
| $8.89M | 1.34% | 7.03% | Not reported | Q4 2023 | |
| $6.23M | 0.94% | 9.24% | Not reported | Q4 2023 | |
| $3.1M | 0.47% | 1.86% | Not reported | Q4 2023 | |
| $1.89M | 0.29% | 0.02% | -57.8% | Q4 2023 | |
| $477K | 0.07% | 0.52% | Not reported | Q4 2023 | |
| Q4 2025Reported Feb 12, 202618 positions | |||||
| $265M | 35.59% | 7.90% | Not reported | Q1 2024 | |
| $233M | 31.31% | 7.68% | Not reported | Q2 2024 | |
| $85.3M | 11.48% | 5.80% | -4.3% | Q4 2024 | |
| $51.4M | 6.92% | 17.96% | Not reported | Q1 2025 | |
| $21.3M | 2.87% | 3.26% | +16.2% | Q4 2024 | |
| $20.8M | 2.79% | 0.52% | -9.9% | Q2 2024 | |
| $15.9M | 2.14% | 0.10% | -4.8% | Q3 2024 | |
| $12.9M | 1.74% | 0.43% | -1.1% | Q4 2023 | |
| $12.2M | 1.64% | 3.35% | Not reported | Q4 2024 | |
| $6.89M | 0.93% | 7.24% | Not reported | Q4 2023 | |
| $6.2M | 0.83% | 9.24% | -11.3% | Q4 2023 | |
| CPCRNXCrinetics Pharmaceuticals, Inc. | $4.32M | 0.58% | 0.10% | -35.2% | Q1 2024 |
| $4.27M | 0.57% | 0.06% | -46.4% | Q4 2023 | |
| $1.96M | 0.26% | 0.57% | -30.1% | Q4 2023 | |
| $1.79M | 0.24% | 1.92% | Not reported | Q4 2023 | |
| $376K | 0.05% | 0.52% | Not reported | Q4 2023 | |
| $332K | 0.04% | 0.08% | -52.2% | Q1 2024 | |
| $141K | 0.02% | 0.06% | Not reported | Q2 2025 | |
| Q3 2025Reported Nov 14, 202522 positions | |||||
| $257M | 44.78% | 8.14% | Not reported | Q1 2024 | |
| $96.1M | 16.77% | 7.87% | Not reported | Q2 2024 | |
| $61.8M | 10.78% | 6.08% | Not reported | Q4 2024 | |
| $52.1M | 9.08% | 18.01% | Not reported | Q1 2025 | |
| $18.7M | 3.26% | 0.58% | -14.7% | Q2 2024 | |
| MMRUSMerus N.V. | $17.6M | 3.06% | 0.25% | -1.4% | Q1 2024 |
| $9.81M | 1.71% | 0.11% | -7.1% | Q3 2024 | |
| $9.67M | 1.69% | 3.09% | Not reported | Q4 2024 | |
| $7.76M | 1.35% | 10.42% | -5.4% | Q4 2023 | |
| $7.68M | 1.34% | 3.73% | Not reported | Q4 2024 | |
| $7.45M | 1.30% | 0.51% | +242.3% | Q4 2023 | |
| $6.36M | 1.11% | 7.33% | Not reported | Q4 2023 | |
| CPCRNXCrinetics Pharmaceuticals, Inc. | $5.96M | 1.04% | 0.15% | Not reported | Q1 2024 |
| $5.7M | 0.99% | 0.11% | -51.1% | Q4 2023 | |
| $3.19M | 0.56% | 0.82% | Not reported | Q4 2023 | |
| $2M | 0.35% | 1.83% | Not reported | Q4 2023 | |
| $1.3M | 0.23% | 0.34% | Not reported | Q1 2024 | |
| $806K | 0.14% | 0.20% | -61.3% | Q1 2024 | |
| $758K | 0.13% | 0.01% | Not reported | Q4 2023 | |
| $726K | 0.13% | 0.53% | Not reported | Q4 2023 | |
| $573K | 0.10% | 0.03% | Not reported | Q2 2024 | |
| $563K | 0.10% | 0.07% | Not reported | Q2 2025 | |
Premium opens every quarter this fund has filed